Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders
November 16, 2022   

Patients with anxiety disorders need treatment options beyond psychotropic medications, which are sometimes not effective or preferred. Mindfulness-based interventions have become more acceptable in the United States and have been shown to reduce anxiety compared to treatment as usual...
 Continue reading (Members only)
2022 NEI Congress Extended Q&A
November 10, 2022   

The NEI Podcast sat down with some of our esteemed Congress Faculty members to address some of the unanswered questions from their presentations...
 Continue reading
Highlights from 2022 NEI Congress: Management of Agitation Associated With Alzheimer’s Dementia
November 6, 2022   

When a patient presents with agitation it represents a substantial challenge to mental health professionals, especially if the agitation is accompanied by psychotic symptoms or progresses to violence or aggression. At the 2022 NEI Congress, Dr. Stephen M. Stahl delivered a presentation on best practices for the management of agitation in patients with Alzheimer’s dementia...
 Continue reading
Highlights from 2022 NEI Congress: Suicide Prevention
November 5, 2022   

Suicide is a complicated, multi-faceted phenomenon that impacts individuals and communities on a global level. Novel attitudes toward mental health in general and suicide specifically are reflected in the growing suicide prevention movement that has recently emerged in the United States, the United Kingdom, Australia, and other nations. While suicide remains unpredictable, a large body of growing scientific research suggests that it can be prevented...
 Continue reading
Highlights from 2022 NEI Congress: Mood Disorders
November 4, 2022   

The 2022 NEI Congress included multiple sessions highlighting the utmost importance of the need for a correct and timely diagnosis of patients presenting with symptoms of various mood disorders...
 Continue reading
Highlights from 2022 NEI Congress: Pre-Conference Precision Psychiatry Workshop
November 3, 2022   

This year’s NEI Congress includes the exciting pre-conference workshop on precision psychiatry. Dr. Jeffrey Strawn kicked off the workshop with “Blue Genes: Using Pharmacogenetics to Guide Prescribing,” describing how clinicians can identify patients for whom pharmacogenetic testing can be appropriate, as well as how to interpret pharmacogenetic test results...
 Continue reading
2022 NEI Congress Young Investigator Poster Competition Winners
November 2, 2022   

The 2022 NEI Congress Scientific Poster Session was held on Friday, November 4th and featured 116 posters, with an additional 22 posters presented virtually, covering the full spectrum of mental health research and clinical data. Among them, three particularly stood out for the quality of their data and contributions to the field. Presented below are the winners of the 2022 NEI Congress Young Investigator Poster Competition....
 Continue reading
Psilocybin for Treatment of Alcohol Use Disorder
October 28, 2022   

Pharmacological treatments for Alcohol Use Disorder (AUD) have remained scarce throughout modern medical times, however, recent research is revisiting the old idea of treating AUD with psilocybin mushrooms (aka magic mushrooms). In a recent study...
 Continue reading
ADHD Polygenic Risk Scores Impact On Outcomes
October 25, 2022   

Early identification of ADHD is critical when it comes to mitigating negative developmental consequences associated with the disorder. However, this can be especially difficult and there are currently no concrete biomarkers used to diagnose ADHD. A recent ...
 Continue reading (Members only)
Early Ketamine Effects on Belief-Updating Biases in Patients With Treatment-Resistant Depression
October 23, 2022   

Clinical research has demonstrated that persistent negative beliefs preserve depression and that subanesthetic ketamine infusions induce rapid antidepressant effects. A study was recently conducted to examine whether ketamine alters belief updating and how such cognitive effects are associated with the clinical effects of ketamine. The study was an...
 Continue reading (Members only)
Top of Page